SPHINGOTEC GMBH
SphingoTec is a biomaker company that develops and markets in vitro diagnostic solutions for novel and proprietary blood-based protein biomarkers. They also develop microtiter plates, which are a standard tool in analytical research and diagnostic testing laboratories. They develop biomakers to address diagnostically underserved critical care conditions such as acute kidney injury, sepsis, and acute heart failure.
SPHINGOTEC GMBH
Industry:
Biotechnology
Founded:
2002-01-01
Address:
Hohen Neuendorf, Brandenburg, Germany
Country:
Germany
Website Url:
http://www.sphingotec.com
Total Employee:
11+
Status:
Active
Total Funding:
1.5 M EUR
Technology used in webpage:
Domain Not Resolving SPF DMARC Newsletter2Go
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
FloBio
FloBio develops point-of-care diagnostics for bleeding risk based on real-time blood analysis.
Invisible Sentinel
At Invisible Sentinel, we develop first in class, next generation technologies for a safer food supply.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
4TEEN4 Pharmaceuticals
4TEEN4 Pharmaceuticals develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Employees Featured
Founder
Investors List
HBM Partners
HBM Partners investment in Series B - Sphingotec GmbH
HBM Healthcare Investments
HBM Healthcare Investments investment in Series B - Sphingotec GmbH
HBM Healthcare Investments
HBM Healthcare Investments investment in Convertible Note - Sphingotec GmbH
HBM Partners
HBM Partners investment in Convertible Note - Sphingotec GmbH
HBM Healthcare Investments
HBM Healthcare Investments investment in Convertible Note - Sphingotec GmbH
Key Employee Changes
Official Site Inspections
http://www.sphingotec.com Semrush global rank: 15.62 M Semrush visits lastest month: 2
- Host name: nis-p0-proxy-01.neusta-is.de
- IP address: 185.48.220.211
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Sphingotec GmbH"
About Us - sphingotec.com
SphingoTec is a privately held company with its headquarter in Hennigsdorf near Berlin and with a wholly-owned subsidiary in San Diego, USA. The headquarter has a long history of biomarker …See details»
SphingoTec - The Biomarker Company - sphingotec.com
SphingoTec announces the successful closing of a Series C financing round. The raised capital will allow the company to reach profitability through sustained and strategic commercialization …See details»
Meet our Team - sphingotec.com
Deborah Bergmann has been an integral part of SphingoTec's journey from its inception, contributing significantly across various domains, including research and development, …See details»
Sphingotec GmbH - Crunchbase Company Profile
Organization. Sphingotec GmbH . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ...See details»
SphingoTec - LinkedIn
SphingoTec | 2,382 followers on LinkedIn. Improving patient outcomes with innovative diagnostics for acute care: Actionable insights in real-time | SphingoTec GmbH develops innovative biomarkers ...See details»
4TEEN4 Pharmaceuticals - Crunchbase Company …
Contact Email [email protected] Phone Number +49 33 02/2 05 65-0 4TEEN4 Pharmaceuticals GmbH is a biopharmaceutical company developing Procizumab, a humanized antibody targeting human Dipeptidyl Peptidase 3 (DPP3) for the …See details»
Sphingotec Company Profile 2025: Valuation, Funding & Investors
Sphingotec has raised $52.6M. Who are Sphingotec’s investors? The Görlich Group, Think.Health , Deutsche Biotech Innovativ , Gründerstipendium NRW , and HBM Healthcare Investments …See details»
Sphingotec , LLC: Contact Details and Business Profile
IVD tests for SphingoTec's proprietary biomarkers are made available as sphingotest® microtiter plate tests as well as point-of-care tests on the Nexus IB10 immunoassay platform. …See details»
Sphingotec GmbH - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Sphingotec GmbH . 2: …See details»
Sphingotec - HBM Healthcare
Sphingotec develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury and circulatory shock, in …See details»
SphingoTec Company Profile - Office Locations, Competitors
SphingoTec is a company that develops biomarkers for diagnosis, prediction, and monitoring of acute medical conditions. It focuses on acute heart failure, acute kidney injury, and circulatory …See details»
Investor Relations - sphingotec.com
SphingoTec is a privately held company with a long history of biomarker discovery, development and validation. We are the legal manufacturer of the CE IVD microtiter plate assays. …See details»
Sphingotec - VentureRadar
Similar Companies: Lumos Diagnostics USA Privately Held Lumos Diagnostics, a California-based Full Service point-of-care diagnostic development company and previous spinoff from …See details»
SphingoTec - YouTube
SphingoTec develops and markets innovative in vitro diagnostic (IVD) solutions for novel and proprietary blood-based protein biomarkers. Our aspiration is to effectively translate scientific ...See details»
SphingoTec Overview | SignalHire Company Profile
Organization Website: sphingotec.com : SphingoTec industries Biotech: Headquarters Location: Neuendorfstraße, Hennigsdorf, Brandenburg, 16761 DE ... SphingoTec headquarters is in …See details»
sphingotec Company Information - Funding, Investors, and More
Sphingotec is a Hennigsdorf-based medical diagnostics company developing biomarkers and diagnostic technology for clinical applications. Seedtable Score 76 Startups 1See details»
Sphingotec - HBM Partners
Sphingotec develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury and circulatory shock, in …See details»
SphingoTec - Technology Networks
SphingoTec develops and markets innovative <i>in vitro</i> diagnostics solutions for novel and proprietary blood-based protein biomarkers. Their aspiration is to translate scientific …See details»
Sphingotec raises €20m in growth equity financing
Oct 7, 2018 Sphingotec announced it will primarily use the proceeds to roll out the fully automated IB 10 point-of-care (POC) platform for testing of a broad panel of acute blood …See details»
Scientific Publications - sphingotec.com
SphingoTec's biomarker discovery is based on the highest standard of evidence, with over 100 publications, over 100 clinical studies, and more than 100.000 patients enrolled. Browse our …See details»